Programmable Cell Therapy Market
- 2026 年市場規模
- USD 3,470.0 Mn
- 2033 年預估規模
- USD 10,988.2 Mn
- 年複合成長率 CAGR
- 17.9%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
完整報告名稱與涵蓋範圍
Programmable Cell Therapy Market, By Cell Type (T Cells, Natural Killer (NK) Cells, Stem Cells, Others), By Therapy Type (CAR-T Cell Therapy, TCR-T Cell Therapy, CAR-NK Cell Therapy, Engineered Stem Cell Therapy, Others), By Programming Technology (CRISPR-Based Programming, Synthetic Gene Circuits, RNA-Based Programming, Transcriptional/Protein-Level Programming, Others), By Therapeutic Approach (Autologous, Allogeneic, In Vivo Cell Programming), By Application (Oncology, Autoimmune Diseases, Genetic Disorders, Infectious Diseases, Neurological Disorders, Regenerative Medicine, Others), By End User (Hospitals and Specialty Clinics, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs), Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
The global programmable cell therapy market is estimated to be valued at USD 3,470.0 Mn in 2026 and is expected to reach USD 10,988.2 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 17.9% from 2026 to 2033. Programmable cell therapy is the use of genetically modified or molecularly reprogrammed living cells including T cells, NK cells, stem cells and macrophages for defined therapeutic tasks such as identification and destruction of diseased cells. The field combines synthetic biology, CRISPR-based editing of genes, RNA engineering and state-of-the-art cell manufacturing technologies to create targeted treatments, especially for oncology, autoimmune and rare diseases.
The global programmable cell therapy market is gaining momentum, with increased clinical development, regulatory activity and investment in next-generation cell therapies. Programmable cell therapies are becoming a possible approach to treat hard-to-treat diseases through highly specific and durable therapeutic responses due to the development of precision medicine.
Market Dynamics
The global programmable cell therapy market is driven by the advancements in gene-editing technologies such as CRISPR-Cas9, base editing, and prime editing that enhance cell programming precision and flexibility. The growing demand for personalized therapies, extensive clinical development, regulatory approval of cell therapies, and growing investments in allogeneic and next-generation platforms are also supporting the market growth.
However, a number of constraints are present in the market, such as high development and treatment costs, complex manufacturing processes, scalability challenges, and stringent regulatory compliances. Nevertheless, significant opportunities exist within the development of allogeneic, off-the-shelf programmable cell therapies that can improve scalability and accessibility. Expansion into solid tumors, autoimmune and other emerging therapeutic areas, along with the integration of AI and machine learning into cell design and patient selection, is creating new avenues for innovation and accelerating the development of programmable cell therapy platforms.
Key Features of the Study
• This report provides in-depth analysis of the global programmable cell therapy market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global programmable cell therapy market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include CRISPR Therapeutics AG, Senti Biosciences, Inc., Cellectis S.A., Caribou Biosciences, Inc., Allogene Therapeutics, Inc., Century Therapeutics, Inc., Fate Therapeutics, Inc., Sana Biotechnology, Inc., Intellia Therapeutics, Inc., and Cabaletta Bio, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global programmable cell therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global programmable cell therapy market
Market Segmentation
• Cell Type Insights (Revenue, USD Mn, 2021 - 2033)
o T Cells
o Natural Killer (NK) Cells
o Stem Cells
o Others
• Therapy Type Insights (Revenue, USD Mn, 2021 - 2033)
o CAR-T Cell Therapy
o TCR-T Cell Therapy
o CAR-NK Cell Therapy
o Engineered Stem Cell Therapy
o Others
• Programming Technology Insights (Revenue, USD Mn, 2021 - 2033)
o CRISPR-Based Programming
o Synthetic Gene Circuits
o RNA-Based Programming
o Transcriptional/Protein-Level Programming
o Others
• Therapeutic Approach Insights (Revenue, USD Mn, 2021 - 2033)
o Autologous
o Allogeneic
o In Vivo Cell Programming
• Application Insights (Revenue, USD Mn, 2021 - 2033)
o Oncology
o Autoimmune Diseases
o Genetic Disorders
o Infectious Diseases
o Neurological Disorders
o Regenerative Medicine
o Others
• End User Insights (Revenue, USD Mn, 2021 - 2033)
o Hospitals and Specialty Clinics
o Pharmaceutical and Biotechnology Companies
o Academic and Research Institutes
o Contract Research Organizations (CROs)
o Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o CRISPR Therapeutics AG
o Senti Biosciences, Inc.
o Cellectis S.A.
o Caribou Biosciences, Inc.
o Allogene Therapeutics, Inc.
o Century Therapeutics, Inc.
o Fate Therapeutics, Inc.
o Sana Biotechnology, Inc.
o Intellia Therapeutics, Inc.
o Cabaletta Bio, Inc.
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Global Programmable Cell Therapy Market, By Cell Type
Global Programmable Cell Therapy Market, By Therapy Type
Global Programmable Cell Therapy Market, By Programming Technology
Global Programmable Cell Therapy Market, By Therapeutic Approach
Global Programmable Cell Therapy Market, By Application
Global Programmable Cell Therapy Market, By End User
Global Programmable Cell Therapy Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Manufacturing Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Industry Trends
4. Global Programmable Cell Therapy Market, By Cell Type, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o T Cells
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Natural Killer (NK) Cells
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Stem Cells
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Programmable Cell Therapy Market, By Therapy Type, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o CAR-T Cell Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o TCR-T Cell Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o CAR-NK Cell Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Engineered Stem Cell Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Programmable Cell Therapy Market, By Programming Technology, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o CRISPR-Based Programming
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Synthetic Gene Circuits
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o RNA-Based Programming
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Transcriptional/Protein-Level Programming
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Programmable Cell Therapy Market, By Therapeutic Approach, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Autologous
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Allogeneic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o In Vivo Cell Programming
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Programmable Cell Therapy Market, By Application, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Autoimmune Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Genetic Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Infectious Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Neurological Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Regenerative Medicine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Programmable Cell Therapy Market, By End User, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Hospitals and Specialty Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Pharmaceutical and Biotechnology Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Academic and Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Contract Research Organizations (CROs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
10. Global Programmable Cell Therapy Market, By Region, 2021 - 2033, Value (USD Mn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Programming Technology, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Therapeutic Approach, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Programming Technology, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Therapeutic Approach, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Programming Technology, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Therapeutic Approach, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Programming Technology, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Therapeutic Approach, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Programming Technology, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Therapeutic Approach, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Programming Technology, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Therapeutic Approach, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
o South Africa
o North Africa
o Central Africa
11. Competitive Landscape
o CRISPR Therapeutics AG
Company Highlights
Manufacturing Portfolio
Key Developments
Financial Performance
Strategies
o Senti Biosciences, Inc.
Company Highlights
Manufacturing Portfolio
Key Developments
Financial Performance
Strategies
o Cellectis S.A.
Company Highlights
Manufacturing Portfolio
Key Developments
Financial Performance
Strategies
o Caribou Biosciences, Inc.
Company Highlights
Manufacturing Portfolio
Key Developments
Financial Performance
Strategies
o Allogene Therapeutics, Inc.
Company Highlights
Manufacturing Portfolio
Key Developments
Financial Performance
Strategies
o Century Therapeutics, Inc.
Company Highlights
Manufacturing Portfolio
Key Developments
Financial Performance
Strategies
o Fate Therapeutics, Inc.
Company Highlights
Manufacturing Portfolio
Key Developments
Financial Performance
Strategies
o Sana Biotechnology, Inc.
Company Highlights
Manufacturing Portfolio
Key Developments
Financial Performance
Strategies
o Intellia Therapeutics, Inc.
Company Highlights
Manufacturing Portfolio
Key Developments
Financial Performance
Strategies
o Cabaletta Bio, Inc.
Company Highlights
Manufacturing Portfolio
Key Developments
Financial Performance
Strategies
12. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
13. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on ‘Programmable Cell Therapy Market' - Global forecast to 2033
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們